CVS
CVS Health Corporation
Cash flow statement
| USDLine, in USD | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 18.7B | 10.6B | 9.1B | 13.4B | 16.2B | 18.3B | 15.9B | 12.8B | 8.9B | 8.0B | 10.1B | 8.5B | 8.1B | 5.8B | 6.7B | 5.9B | 4.8B | 4.0B | 3.9B | 3.2B |
| 3.14B | 2.83B | 2.78B | 3.03B | 2.73B | 2.52B | 2.44B | 2.46B | 2.04B | 1.92B | 2.22B | 2.37B | 2.14B | 1.98B | 2.03B | 1.87B | 2.01B | 2.55B | 2.18B | 1.81B | |
| Free cash flow | 15.6B | 7.8B | 6.3B | 10.4B | 13.5B | 15.7B | 13.4B | 10.4B | 6.8B | 6.1B | 7.9B | 6.2B | 6.0B | 3.8B | 4.6B | 4.0B | 2.8B | 1.5B | 1.8B | 1.4B |
| Depreciation and amortization | 4.52B | 4.61B | 4.60B | 4.37B | 4.22B | 4.49B | 4.44B | 4.37B | 2.72B | 2.48B | 2.48B | 2.09B | 1.93B | 1.87B | 1.75B | 1.57B | 1.47B | 1.39B | 1.27B | 1.10B |
| Stock-based compensation | 745M | 535M | 540M | 588M | 447M | 484M | 400M | 453M | 280M | 234M | 222M | 230M | 165M | 141M | 132M | 135M | 150M | 165M | 92M | 78M |
| Buybacks | — | 0 | 3.02B | 2.01B | 3.50B | 0 | 0 | 0 | 0 | 4.36B | 4.46B | 5.00B | 4.00B | 3.98B | 4.33B | 3.00B | 1.50B | 2.48B | 23M | 5.37B |
| Dividends paid | 3.42B | 3.40B | 3.37B | 3.13B | 2.91B | 2.63B | 2.62B | 2.60B | 2.04B | 2.05B | 1.84B | 1.58B | 1.29B | 1.10B | 0.83B | 0.67B | 0.48B | 0.44B | 0.38B | 0.32B |
| Dividends per share | 2.66 | 2.66 | 2.66 | 2.42 | 2.20 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.70 | 1.40 | 1.10 | 0.90 | 0.65 | 0.50 | 0.35 | 0.31 | 0.26 | 0.23 |
| Free cash flow margin | 3.7% | 1.9% | 1.7% | 2.9% | 4.2% | 5.4% | 5.0% | 4.0% | 3.5% | 3.3% | 4.5% | 4.0% | 4.3% | 3.0% | 3.8% | 3.7% | 2.9% | 1.5% | 2.0% | 1.9% |